The metabolic syndrome is related to albuminuria in type 2 diabetes

Diabetic Medicine

Volumn 25, Issue 12, 2008, Pages 1412-1418

  Bianchi, C ^b   Penno, G ^b   Daniele, G ^b   Russo, E ^b   Giovannitti, M G ^b   Del Prato, S ^b   Miccoli, R ^a,b  

^a CISANELLO HOSPITAL   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Diabetic nephropathy; Metabolic syndrome; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 57449096148     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02603.x     Document Type: Article

References (42)

1. Ritz E, Rychlik I, Locatelli F, Halimi S. Endstage renal failure in Type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999 34 : 795 808.
2. The 2007 USRDS Healthy People 2010. Annual Data Report (ADR) Atlas. Available at http://www.usrds.org/atlas.htm. Last accessed 1 September 2008.
3. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care 2002 25 : 43 48.
4. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002 106 : 2207 2211.
5. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P et al. Diabetic nephropathy in 27 805 children, adolescents, and adults with Type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007 30 : 2523 2528.
6. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of Type II diabetic patients: a global perspective. Kidney Int 2006 69 : 2057 2063.
7. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 2007 18 : 235 243.
8. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti GC. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993 342 : 883 887.
9. Groop L, Ekstrand A, Forsblom C, Widén E, Groop PH, Teppo AM et al. Insulin resistance, hypertension and microalbuminuria in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993 36 : 642 647.
10. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in Type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002 62 : 963 970.
11. Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M et al. FinnDiane Study Group. Metabolic syndrome in Type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005 28 : 2019 2024.
12. De Cosmo S, Trevisan R, Minenna A, Vedovato M, Viti R, Santini SA et al. Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glomerular filtration rate in patients with Type 2 diabetes. Diabetes Care 2006 29 : 432 434.
13. Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D et al. Identifying patients with Type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant 2008 23 : 1278 1284.
14. Hanai K, Bobazono T, Iwamoto Y. Renal manifestations of metabolic syndrome in Type 2 diabetes. Diabetes Res Clin Prac 2008 79 : 318 324.
15. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L. The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes. Diabetologia 2001 44 : 1148 1154.
16. Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG et al. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with Type 2 diabetes and metabolic syndrome. Nutr Metab Cardiovasc Dis 2007 78 : 246 253.
17. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002 106 : 3143 3421.
18. Lambers Heerspink HJ, Brinkman JW, Bakker SJ, Gansevoort RT, de Zeeuw D. Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Curr Opin Nephrol Hypertens 2006 15 : 631 636.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 470.
20. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003 139 : 137 147.
21. Chen J, Muntner P, Hamm LL Jones DW, Batuman V, Fonseca V et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004 140 : 167 174.
22. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005 16 : 2134 2140.
23. Cull CA, Jensen CC, Retnakaran R, Holman RR. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in Type 2 diabetes mellitus. United Kingdom Prospective Study 78. Circulation 2007 116 : 2119 2126.
24. Caramori ML, Fioretto P, Mauer M. Enhancing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol 2006 17 : 339 352.
25. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007 2 : 581 590.
26. Bruno G, Merletti F, Bargero G, Novelli G, Melis D, Soddu A et al. Estimated glomerular filtration rate, albuminuria and mortality in Type 2 diabetes: the Casale Monferrato study. Diabetologia 2007 50 : 941 948.
27. Ritz E. Heart and kidney: fatal twins? Am J Med, 2006 119 (5 Suppl 1 S31 39.
28. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003 14 : 469 477.
29. Franciosi M, Pellegrini F, Sacco M, De Berardis G, Rossi MC, Strippoli GF et al. IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study. Clin J Am Soc Nephrol 2007 2 : 984 991.
30. Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 2002 13 : 1626 1634.
31. Parvanova AI, Trevisan R, Iliev IP, Dimitrov BD, Vedovato M, Tiengo A et al. Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with Type 2 diabetes and different degrees of urinary albumin excretion. Diabetes 2006 55 : 1456 1462.
32. World Health Organization. Definition, diagnosis and classification of diabetes and its complications. Part 1. in World Healt Org., Diagnosis and classification of diabetes mellitus. Geneva. Tech Resp Ser 1999 N 99.2.
33. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in Type 1 diabetes: 'double diabetes' in the Diabetes Control and Complications Trial. Diabetes Care 2007 30 : 707 712.
34. Metascreen Writing Committee Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicentre diabetes clinic-based survey. Diabetes Care 2006 29 : 2701 2707.
35. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006 23 : 469 480.
36. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 112 : 2735 2752.
37. Lee JE, Huh W, Son HJ, Kim YG, Kim DJ, Lee MK et al. Association of metabolic syndrome with microalbuminuria in non-hypertensive Type 2 diabetic patients. Nephron Clin Pract 2007 106 : c98 c103.
38. Klausen KP, Parving HH, Scharling H, Jensen JS. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med 2007 262 : 470 478.
39. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007 49 : 403 414.
40. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008 371 : 1927 1935.
41. Bruno G, Cavallo-Perin P, Bargero G, Borra N, D'Errico N, Macchia G et al. Cardiovascular risk profile of Type 2 diabetic patients cared for by general practitioners or at a diabetes clinic: a population-based study. J Clin Epidemiol 1999 52 : 413 417.
42. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with Type 2 diabetes. N Engl J Med 2003 348 : 383 393.